Making Informed Decisions on Stroke Prevention: Focus on Older Patients with Atrial Fibrillation

Thursday, June 24, 2021, 8:00 AM - Thursday, June 23, 2022, 11:59 PM

AMA PRA Category 1 Credits™ (1.00 hours), AMA PRA Category 1 Credits™ Designated (1.00 hours)

Join this program as the expert faculty panel provides their insight in applying stroke prevention recommendations to optimize oral anticoagulation for safe and effective stroke prevention in older patients with nonvalvular atrial fibrillation.

The goal of this activity is to improve competence of cardiologists, geriatricians, gerontological nurse practitioners, consultant and senior care pharmacists, and other clinicians in applying stroke prevention recommendations to optimize oral anticoagulation for safe and effective stroke prevention in older patients with nonvalvular atrial fibrillation.

This activity is provided by the University of Cincinnati in collaboration with the American Society of Consultant Pharmacists and Gerontological Advanced Practice Nurses Association.

There are no fees for participating in and receiving CME credit for this online activity.

Click 'register now' to access this activity.

 

1. Describe risk stratification to determine which patients should be treated with anticoagulation therapy for stroke prevention;
2. Apply the latest published guidelines and best practices for employing effective and safe anticoagulation to reduce stroke risk in patients with AF;
3. Examine the evidence for selecting a NOAC product for stroke prevention in AF as it pertains to bleeding risk in patients older than 75 years of age.
4. (Nursing Learning Outcome: Outline optimal stroke prevention recommendations to optimize oral anticoagulation for safe and effective stroke prevention in older patients with nonvalvular atrial fibrillation.)

PHYSICIAN CONTINUING EDUCATION (ACCME)

The University of Cincinnati is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Cincinnati designates this enduring material activity for a maximum of 1.00 AMA PRA Category 1 Credit™. Physicians should claim only the credits commensurate with the extent of their participation in the activity.

The University of Cincinnati and Clinical Care Options are accredited by the ACCME to provide continuing medical education for physicians, and have collaborated to design and execute this activity.

For accreditation purposes, the University of Cincinnati is responsible for certification and documentation of attendance for activity.

The American Academy of Physician Assistants accept certificates of participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME.

NURSING CONTINUING EDUCATION (GAPNA)

This educational activity is jointly provided by Anthony J. Jannetti, Inc. (AJJ), the Gerontological Advanced Practice Nurses Association (GAPNA), and Clinical Care Options. Anthony J. Jannetti, Inc. is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

Anthony J. Jannetti, Inc. is a provider approved by the California Board of Registered Nursing, Provider Number CEP5387.

A maximum of 1.0 contact hour (which includes 0.25 hours of pharmacology credit) may be earned by learners who successfully complete this continuing nursing education activity.

PHARMACY CONTINUING EDUCATION (ASCP)

The American Society of Consultant Pharmacists is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ASCP designates this continuing education activity for 1.0 contact hour (0.10 CEUs) of the Accreditation Council for Pharmacy Education.

Universal Activity Number: UAN: 0203-9999-21-021-L01-P

Type of Activity: Application

You must participate in this activity in its entirety and complete the evaluation form to receive CPE credit. Partial credit will not be granted. The course should be posted to CPE Monitor within 60 days of evaluation completion.

CONFLICT OF INTEREST POLICY

The University is committed to providing its learners with high-quality CME activities that promote improvements or quality in healthcare and not a specific proprietary business interest of a commercial interest. The University requires instructors, planners, managers, and other individuals who are in a position to control the content of this activity to disclose all relationships with ineligible companies (commercial interest) within the last 24-months. All identified conflicts of interests are thoroughly vetted and mitigated according to the ACCME and University’s policy. All educational materials are reviewed for fair balance, scientific objectivity, and levels of evidence. Disclosure will be made at the time of activity.

Staff Disclosures
The University of Cincinnati; American Society of Consultant Pharmacists; Anthony J. Jannetti, Inc. (AJJ); the Gerontological Advanced Practice Nurses Association (GAPNA); Clinical Care Options, LLC; and the peer/content reviewers for this activity have no relevant conflicts of interest to report.

Disclosure of Unlabeled Use
This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Neither the University of Cincinnati nor Clinical Care Options, LLC., recommends the use of any agent outside of the labeled indications. The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the University of Cincinnati or Clinical Care Options, LLC. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer Statement
Learners have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Mitigation of Relevant Financial Relationships

The University of Cincinnati adheres to the ACCME’s Standards for Integrity and Independence in Accredited Continuing Education. Any individuals in a position to control the content of a CME activity, including faculty, planners, reviewers,  or others, are required to disclose all financial relationships with ineligible entities (commercial interests) within the last 24-months. All relevant conflicts of interest have been mitigated prior to the commencement of the activity.

Information regarding the new updated ACCME Standards for Integrity and Independence in Accredited Continuing Education can be found on the ACCME website.

This educational activity is supported by an educational grant from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC.